IWMvsXPH
iShares Russell 2000 ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IWM | XPH | |
|---|---|---|
| Expense ratio | 0.19% | 0.35% |
| Assets | $74.2B | $440M |
| Net flow, 1 month | −$1.6B | −$80M |
| Net flow, 1 year | −$4.4B | +$206M |
| Return, YTD | +13.8% | +14.2% |
| Return, 1 year | +11.9% | +30.2% |
| Avg daily volume | 24.9M | 198K |
| Holdings | 1941 | 41 |
| Listed | May 22, 2000 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS